Megafit-G Tablet
Marketer
Rapid Solutions (I) Private Limited
Salt Composition
Gabapentin (100mg) + Methylcobalamin (500mcg)
Overview Megafit-G Tablet
Neuropathic pain is effectively managed with the combined-ingredient formulation, NeuroCalm tablets. These tablets reduce pain signals by regulating calcium channel function within nerve cells. NeuroCalm tablets are administered orally, with or without food, ideally before sleep. Maintaining a consistent daily dosing schedule ensures stable medication levels. Always adhere to your physician's prescribed dosage and treatment duration. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation of this medication should only occur under medical supervision. Commonly reported side effects include nausea, peripheral swelling, incoordination, blurred vision, fever, and involuntary eye movements (nystagmus). Drowsiness and dizziness may also occur; avoid activities requiring alertness until the medication's effects are known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor prior to initiating treatment. While generally compatible with other medications, some drugs (including antacids and alcohol) may interfere with its efficacy and increase adverse reactions.
Uses of Megafit-G Tablet
Managing Neuropathic Pain
Major Benefits of Megafit-G Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megafit-G Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Megafit-G Tablet:
- Dizziness
- Sleepiness
- Tiredness
How to use Megafit-G Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Megafit-G Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Megafit-G Tablet works:
Megafit-G Tablets contain Gabapentin and Methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta calcium channel ligand, reduces pain signaling in nerve cells. Methylcobalamin, a B vitamin, supports myelin production, protecting and repairing nerve fibers. This dual action provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Megafit-G tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Megafit-G Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Megafit-G Tablets while breastfeeding is likely inadvisable. Preliminary data in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Megafit-G Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Megafit-G Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Megafit-G Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Megafit-G Tablet :
Should you forget a Megafit-G Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Megafit-G Tablet
Label | Value |
---|---|
Developing Good Habits | No. |
Treatment Category | Neuroscience Central Nervous System |